Cargando…

25-Hydroxyvitamin D potentializes extracellular cathelicidin release from human PBMC stimulated ex vivo with either bacterial (LPS) or viral (P: IC) mimetics

Human cathelicidin refers to the cationic antimicrobial peptide hCAP18/LL-37. LL-37 is formed by cleavage of the propeptide hCAP18 coded by the CAMP gene. The active form of vitamin D, 1,25-dihydroxyvitamin D (1,25(OH)D), has been shown to induce the CAMP gene expression through promoter activation....

Descripción completa

Detalles Bibliográficos
Autores principales: Aldekwer, Sahar, Goncalves-Mendes, Nicolas, Bingula, Rea, Martinroche, Guillaume, Lanchais, Kassandra, Rougé, Stéphanie, Farges, Marie-Chantal, Rossary, Adrien, Diab-Assaf, Mona, Vasson, Marie-Paule, Talvas, Jérémie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727486/
https://www.ncbi.nlm.nih.gov/pubmed/34985728
http://dx.doi.org/10.1007/s13105-021-00868-z
_version_ 1784626540961595392
author Aldekwer, Sahar
Goncalves-Mendes, Nicolas
Bingula, Rea
Martinroche, Guillaume
Lanchais, Kassandra
Rougé, Stéphanie
Farges, Marie-Chantal
Rossary, Adrien
Diab-Assaf, Mona
Vasson, Marie-Paule
Talvas, Jérémie
author_facet Aldekwer, Sahar
Goncalves-Mendes, Nicolas
Bingula, Rea
Martinroche, Guillaume
Lanchais, Kassandra
Rougé, Stéphanie
Farges, Marie-Chantal
Rossary, Adrien
Diab-Assaf, Mona
Vasson, Marie-Paule
Talvas, Jérémie
author_sort Aldekwer, Sahar
collection PubMed
description Human cathelicidin refers to the cationic antimicrobial peptide hCAP18/LL-37. LL-37 is formed by cleavage of the propeptide hCAP18 coded by the CAMP gene. The active form of vitamin D, 1,25-dihydroxyvitamin D (1,25(OH)D), has been shown to induce the CAMP gene expression through promoter activation. We previously failed to demonstrate in a clinical trial that supplementation of 25-hydroxyvitamin D (25(OH)D) improves LL-37 serum levels. The aim of this work was to evaluate the impact of 25(OH)D supplementation on intracellular expression of CAMP and secretion of LL-37 in an ex vivo model using the peripheral blood mononuclear cells (PBMC). PBMC collected from healthy donors and incubated with different concentrations of 25(OH)D (0 ng/ml: control (D0); 25 ng/ml: deficient (D25); 75 ng/ml: physiological (D75); 125 ng/ml: supraphysiological (D125)) were stimulated or not with lipopolysaccharide (LPS, 100 ng/ml) or synthetic double-stranded RNA Poly (I: C) (PIC, 10 µg/ml). The intracellular expressions of the CAMP gene and the hCAP18 peptide were measured respectively after 24-h and 48-h incubation periods. The concentration of LL-37 was determined in the culture medium after 48-h incubation. 25(OH)D significantly induced CAMP gene expression at 24 h with a maximum effect at a dose of D125 in either unstimulated (tenfold expression) or stimulated (LPS: 100-fold expression; PIC: 15-fold expression) conditions. Intracellular hCAP18 peptide was overexpressed at 48 h under unstimulated (1.5-fold, D125) and stimulated conditions, LPS (twofold, D125) and PIC (2.5-fold, D125). The secretion of LL-37 in the culture medium was significantly induced by 25(OH)D only in both stimulated (LPS and PIC) conditions in a dose-dependent manner. Our results demonstrate that 25(OH)D incubation increases intracellular expression of CAMP and hCAP18, but extracellular secretion of LL-37 antimicrobial peptide is increased by 25(OH)D only when PBMC from healthy donors were stimulated with bacterial or viral immune mimetic.
format Online
Article
Text
id pubmed-8727486
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-87274862022-01-05 25-Hydroxyvitamin D potentializes extracellular cathelicidin release from human PBMC stimulated ex vivo with either bacterial (LPS) or viral (P: IC) mimetics Aldekwer, Sahar Goncalves-Mendes, Nicolas Bingula, Rea Martinroche, Guillaume Lanchais, Kassandra Rougé, Stéphanie Farges, Marie-Chantal Rossary, Adrien Diab-Assaf, Mona Vasson, Marie-Paule Talvas, Jérémie J Physiol Biochem Original Article Human cathelicidin refers to the cationic antimicrobial peptide hCAP18/LL-37. LL-37 is formed by cleavage of the propeptide hCAP18 coded by the CAMP gene. The active form of vitamin D, 1,25-dihydroxyvitamin D (1,25(OH)D), has been shown to induce the CAMP gene expression through promoter activation. We previously failed to demonstrate in a clinical trial that supplementation of 25-hydroxyvitamin D (25(OH)D) improves LL-37 serum levels. The aim of this work was to evaluate the impact of 25(OH)D supplementation on intracellular expression of CAMP and secretion of LL-37 in an ex vivo model using the peripheral blood mononuclear cells (PBMC). PBMC collected from healthy donors and incubated with different concentrations of 25(OH)D (0 ng/ml: control (D0); 25 ng/ml: deficient (D25); 75 ng/ml: physiological (D75); 125 ng/ml: supraphysiological (D125)) were stimulated or not with lipopolysaccharide (LPS, 100 ng/ml) or synthetic double-stranded RNA Poly (I: C) (PIC, 10 µg/ml). The intracellular expressions of the CAMP gene and the hCAP18 peptide were measured respectively after 24-h and 48-h incubation periods. The concentration of LL-37 was determined in the culture medium after 48-h incubation. 25(OH)D significantly induced CAMP gene expression at 24 h with a maximum effect at a dose of D125 in either unstimulated (tenfold expression) or stimulated (LPS: 100-fold expression; PIC: 15-fold expression) conditions. Intracellular hCAP18 peptide was overexpressed at 48 h under unstimulated (1.5-fold, D125) and stimulated conditions, LPS (twofold, D125) and PIC (2.5-fold, D125). The secretion of LL-37 in the culture medium was significantly induced by 25(OH)D only in both stimulated (LPS and PIC) conditions in a dose-dependent manner. Our results demonstrate that 25(OH)D incubation increases intracellular expression of CAMP and hCAP18, but extracellular secretion of LL-37 antimicrobial peptide is increased by 25(OH)D only when PBMC from healthy donors were stimulated with bacterial or viral immune mimetic. Springer Netherlands 2022-01-05 2022 /pmc/articles/PMC8727486/ /pubmed/34985728 http://dx.doi.org/10.1007/s13105-021-00868-z Text en © The Author(s) under exclusive licence to University of Navarra 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Article
Aldekwer, Sahar
Goncalves-Mendes, Nicolas
Bingula, Rea
Martinroche, Guillaume
Lanchais, Kassandra
Rougé, Stéphanie
Farges, Marie-Chantal
Rossary, Adrien
Diab-Assaf, Mona
Vasson, Marie-Paule
Talvas, Jérémie
25-Hydroxyvitamin D potentializes extracellular cathelicidin release from human PBMC stimulated ex vivo with either bacterial (LPS) or viral (P: IC) mimetics
title 25-Hydroxyvitamin D potentializes extracellular cathelicidin release from human PBMC stimulated ex vivo with either bacterial (LPS) or viral (P: IC) mimetics
title_full 25-Hydroxyvitamin D potentializes extracellular cathelicidin release from human PBMC stimulated ex vivo with either bacterial (LPS) or viral (P: IC) mimetics
title_fullStr 25-Hydroxyvitamin D potentializes extracellular cathelicidin release from human PBMC stimulated ex vivo with either bacterial (LPS) or viral (P: IC) mimetics
title_full_unstemmed 25-Hydroxyvitamin D potentializes extracellular cathelicidin release from human PBMC stimulated ex vivo with either bacterial (LPS) or viral (P: IC) mimetics
title_short 25-Hydroxyvitamin D potentializes extracellular cathelicidin release from human PBMC stimulated ex vivo with either bacterial (LPS) or viral (P: IC) mimetics
title_sort 25-hydroxyvitamin d potentializes extracellular cathelicidin release from human pbmc stimulated ex vivo with either bacterial (lps) or viral (p: ic) mimetics
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727486/
https://www.ncbi.nlm.nih.gov/pubmed/34985728
http://dx.doi.org/10.1007/s13105-021-00868-z
work_keys_str_mv AT aldekwersahar 25hydroxyvitamindpotentializesextracellularcathelicidinreleasefromhumanpbmcstimulatedexvivowitheitherbacteriallpsorviralpicmimetics
AT goncalvesmendesnicolas 25hydroxyvitamindpotentializesextracellularcathelicidinreleasefromhumanpbmcstimulatedexvivowitheitherbacteriallpsorviralpicmimetics
AT bingularea 25hydroxyvitamindpotentializesextracellularcathelicidinreleasefromhumanpbmcstimulatedexvivowitheitherbacteriallpsorviralpicmimetics
AT martinrocheguillaume 25hydroxyvitamindpotentializesextracellularcathelicidinreleasefromhumanpbmcstimulatedexvivowitheitherbacteriallpsorviralpicmimetics
AT lanchaiskassandra 25hydroxyvitamindpotentializesextracellularcathelicidinreleasefromhumanpbmcstimulatedexvivowitheitherbacteriallpsorviralpicmimetics
AT rougestephanie 25hydroxyvitamindpotentializesextracellularcathelicidinreleasefromhumanpbmcstimulatedexvivowitheitherbacteriallpsorviralpicmimetics
AT fargesmariechantal 25hydroxyvitamindpotentializesextracellularcathelicidinreleasefromhumanpbmcstimulatedexvivowitheitherbacteriallpsorviralpicmimetics
AT rossaryadrien 25hydroxyvitamindpotentializesextracellularcathelicidinreleasefromhumanpbmcstimulatedexvivowitheitherbacteriallpsorviralpicmimetics
AT diabassafmona 25hydroxyvitamindpotentializesextracellularcathelicidinreleasefromhumanpbmcstimulatedexvivowitheitherbacteriallpsorviralpicmimetics
AT vassonmariepaule 25hydroxyvitamindpotentializesextracellularcathelicidinreleasefromhumanpbmcstimulatedexvivowitheitherbacteriallpsorviralpicmimetics
AT talvasjeremie 25hydroxyvitamindpotentializesextracellularcathelicidinreleasefromhumanpbmcstimulatedexvivowitheitherbacteriallpsorviralpicmimetics